SCHEMBL4949650

SCHEMBL4949650

CCCSCC(NC(=O)C(C)C(=O)O)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ACE P12821 11/20 0.46
METAP2 P50579 1/20 0.40
METAP1 P53582 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4956751 0.90 ACE (0.42) ACE
SCHEMBL4955844 0.87 ACE (0.46) ACEMETAP2METAP1
SCHEMBL4949349 0.86 ACE (0.45) ACE
SCHEMBL4952818 0.85 MME (0.38) ACE
SCHEMBL5329907 0.82 ACE (0.42) ACEMETAP2METAP1
SCHEMBL4956217 0.81 MAPT (0.50) ACEMETAP2METAP1
SCHEMBL14991078 0.81 MAPT (0.50) ACEMETAP2METAP1
SCHEMBL4954815 0.80 ACE (0.44) ACE
SCHEMBL4954319 0.79 NOD1 (0.41) ACEMETAP2METAP1
SCHEMBL4952040 0.78 NOD1 (0.47) ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465471-B2 Palatability of aquaculture feed NOVUS INTERNATIONAL, INC. (US) 2008-12-16 US disclosed
WO-2007147155-A1 POLYOL ESTER COMPOUNDS NOVUS INTERNATIONAL INC. (US) 2007-12-21 WO disclosed
US-20070292485-A1 POLYOL ESTER COMPOUNDS NOVUS INTERNATIONAL INC. (US) 2007-12-20 US disclosed
US-20050215623-A1 Palatability of aquaculture feed NOVUS INTERNATIONAL, INC. (US) 2005-09-29 US disclosed
US-20040175434-A1 Antimicrobial compositions NOVUS INTERNATIONAL, INC. 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070292485-A1 POLYOL ESTER COMPOUNDS PNLIP, ELOVL1, ELOVL5 ACE 837/4885METAP2 2666/4885METAP1 3714/4885
US-20050215623-A1 Palatability of aquaculture feed TAS2R3, TAS2R1, TAS2R20 ACE 518/4885METAP2 3008/4885METAP1 2414/4885
US-20040175434-A1 Antimicrobial compositions MRPL21, FPR1, ARG1 ACE 2720/4885METAP2 3176/4885METAP1 1638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.